Insider Profile
Keen, Matthew
1
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Mar 10, 2026
Most Recent Trade
20
Credibility
Score
71%
Hit Rate
+2.2%
Avg 90d Return
+11.5%
Median 90d Return
7
Evaluated Trades
+11.5%
Best Trade
-19.8%
Worst Trade
Hit rate and returns are based on 7 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Date Company Role Nature Dir. Shares Price Value Score
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Sell 1,264 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Sell 182 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Comp. Grant Buy 211 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 19 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 78 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 90 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 96 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 669 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Sell 148 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Sell 171 58
Mar 04, 2026 $TRI
Thomson Reuters Corp
Comp. Grant Buy 822 58
Mar 04, 2026 $TRI
Thomson Reuters Corp
Comp. Grant Buy 1,643 58
Dec 31, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 18 58
Sep 30, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 13 58
Jun 30, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 11 58
Dec 10, 2024 $TRI
Thomson Reuters Corp
Exercise Buy 154 58
Dec 10, 2024 $TRI
Thomson Reuters Corp
Exercise Sell 292 58
Mar 10, 2024 $TRI
Thomson Reuters Corp
Exercise Sell 168 58
Mar 10, 2024 $TRI
Thomson Reuters Corp
Exercise Sell 235 58
Mar 10, 2024 $TRI
Thomson Reuters Corp
Exercise Buy 89 58
Mar 10, 2024 $TRI
Thomson Reuters Corp
Exercise Sell 864 58
Mar 10, 2024 $TRI
Thomson Reuters Corp
Exercise Sell 1,456 58
Mar 10, 2024 $TRI
Thomson Reuters Corp
Exercise Buy 124 58
Mar 10, 2024 $TRI
Thomson Reuters Corp
Exercise Buy 771 58
Mar 10, 2024 $TRI
Thomson Reuters Corp
Exercise Buy 457 58
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.